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AbstrAct  
Background: the ectonucleotide Pyrophosphatase Phosphodiesterase1 (enPP1)
polymorphisms have been associated with metabolic traits. there is no data on the 
effect of enPP1 in south African children or adults.  
Objective: to investigate the role of K121Q (rs1044498), rs997509 and rs9402349 in 
obesity and other components of the metabolic syndrome.
Design: A case-control study. 
Subjects: sixty four obese and 64 lean mixed ancestry learners. 
Setting: western cape, south Africa.
Main outcome measure: the enPP1 rs997509t allele is independently 
associated with obesity in children of mixed ancestry from south Africa.  
Results: The T allele frequency of the rs997509 differed significantly between obese  
and controls, p=0.0100 and increased the risk of being obese, p = 0.0238. furthermore, 
the estimated effect of the t allele was an increase of 8.6 cm in waist circumference, 
10.2 kg in weight and a corresponding 4.9 kg/m2 in bmi. individuals carrying both the 
121Q and the t allele of rs997509 were more associated with obesity (odds ratio = 3.85, 
95% ci: 1.13 to 13.09) whilst those carrying the c allele of rs997509 in the presence of 
121Q were likely to be lean with odds ratio of obesity 0.41 (95% ci: 0.19 to 0.87). 
Conclusion: Our findings suggest that ENPP1 polymorphisms may contribute to 
different metabolic characteristics, all of which are associated with insulin resistance 
in mixed ancestry children of south Africa. however, a larger study is required to 
confirm findings of this study.
  
introduction  
the attention has previously been focused on under-
nutrition in south African children, but recent survey 
data indicate that the country is faced with a rapid 
increase in childhood obesity of up to 20% among 
children and adolescents between the ages of 1-19 
years old (1-3). A national survey conducted in 10,195 
south African 6 - 13 year old primary school learners 
reported an overweight prevalence of 10.8 and 13.0% 
in boys and girls respectively (4). overweight children 
tend to become overweight adults, and are thus at an 
increased risk of developing insulin resistance (5, 6), 
insulin resistance and obesity are considered to be the 
driving force of metabolic syndrome (7,8)  . recently, 
in a study of learners aged 10 - 16 years, we showed 
that the metabolic syndrome was more prevalent in 
obese subjects using either the national cholesterol 
education Programme expert Panel on detection, 
evaluation, and treatment of high blood cholesterol 
in Adults Adult treatment Panel iii (nceP AtP 
iii) or international diabetes federation (idf) (9). 
 multiple studies assessing heritability within 
families have shown compelling evidence for the 
significant genetic influence on obesity. Genetic factors 
are currently estimated to account for approximately 
40-70% of the variance in human adiposity (10). 
ectonucleotide Pyrophosphatase Phosphodiesterase 
1 (enPP1) is a promising candidate gene for early 
onset obesity and related sequelae. enPP1, a class 
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ii transmembrane glycoprotein has been shown 
to inhibit insulin receptor function by decreasing 
insulin-induced tyrosine phosphorylation in 
peripheral tissues, including liver, muscle and fat 
(11, 12). while the physiological function of enPP1 
is not well characterised, studies in humans have 
shown a correlation between over expression of 
enPP1 and insulin resistance, obesity, and type 2 
diabetes, particularly the substitution of a lysine with 
a glutamine at codon 121 (k121Q) (13-15). recently, 
another  single nucleotide Polymorphism (snP) 
within k121Q haploblock, rs997509 has been associated 
with diabetes and metabolic abnormalities in obese 
children (16,17). the rs997509 is located in the 3’ end 
of intron 1 and consists in a substitution of a cystosine 
(c) with a thymine (t).
 there is currently no data showing the 
contribution of genetic factors to childhood obesity 
in south African children and adolescents. the aims 
of our study were to genotype the k121Q (rs1044498), 
rs997509 and rs9402349 variants among mixed 
ancestry obese and normal weight children from 
south Africa, and to establish their role in obesity 
and other components of the metabolic syndrome. 
the mixed ancestry population is the majority 
group in the western cape, south Africa (18). 
mAteriAls And methods  
Ethics Statement: ethical Approval was obtained from 
the research ethics committee of the university of 
stellenbosch (Project number: n07/07/ 160) and 
from the faculty of health and wellness science 
ethics committee, cape Peninsula university of 
technology (Project reference number: cPut/ hAs- 
rec 0016). written consent was obtained from the 
parent or guardian of each learner, and oral assent 
from children was obtained on the sampling day. 
Study population: in an epidemiological study that 
aimed to determine the prevalence of metabolic 
syndrome and obesity, learners were recruited 
through a proportionally stratified multistage 
random sampling technique from government 
funded primary and secondary schools (9). of the 
1564 learners that responded (65%), the 861 (55.1%) 
were of mixed ancestry. obesity was assessed using 
gender-age specific cut-off points international 
references provided by the international task force 
as developed by cole and his co-workers (19). 
the 64 (7.4%) that were found to be obese and 64 
normal weight unrelated mixed ancestry learners, 
all consented for further genetic investigations. 
Anthropometric measurements (body weight and 
height; waist and hip circumference; waist-hip ratio 
and skinfold thickness measurements etc), were 
performed on all learners. body mass index (bmi) 
was calculated as weight per square meter (kg/
m2). three readings were taken for blood pressure, 
waist and hip circumferences. skinfold thickness 
was measured at three different body sites, namely 
subscapular, supra-ileac and upper arm. 
 finger prick blood was used for the estimation 
of fasting plasma glucose and lipid levels using the 
Accutrend GCT glucometer and CardioCheck TM, 
P.A analyser (Polymer technology systems, inc, 
usA), respectively. blood pressure measurements 
were performed using a semi-automatic digital blood 
pressure monitor (rossmax PA, usA) according the 
who guidelines (20). 
Genotyping of the ENPP: Genomic  DNA  was extracted 
from either whole blood collected in vacutainer 
ethylenediamine tetra-acetic Acid (eotA) tubes, 
or from capillary blood collected onto whatman 
ftA® cards (merck laboratories, united kingdom), 
All learners were genotyped for the k121Q (in 
exon 4), rs997509 (at the 3’ end of intron 1) and 
rs9402349 (in intron 9) snP’s by Pcr and subsequent 
sequencing. the following primers were used for 
amplifying the respective fragments,: k121Q, f: 
5’- ACTTTGGACATGTTGAATTTGAGAC-3’ and 
R:5’-ACACACAGAACTGTAGTTGATGCAG-3’; 
rs997509, F:-5’CCTTCAGTGTATAACAGTCT 
TTGC-3’ and R: 5’-CCCATTCTCCACTCTTCTGG-3’; 
rs9402349, F: 5’-TTCCTCTGGACA CAGGCTTT- 3’ 
and R: 5’- GAGGTGGAGATTGCAGTGAA-3’. All 
primers were designed using Primer3plus (http: 
www.primer3plus.com).  sequencing was done using 
the bigdye terminator.  sequence ready reaction kit 
version 3.1 (Applied biosystems) and the products 
electrophoretically separated on a 3130xl Genetic 
Analyzer (Applied biosystems). the sequencing 
data were analysed using the sequencing Analysis 
version 5.2 (Applied biosystems) and bioedit (21) 
software programmes. 
Statistical Analysis: data were analysed using the freely 
available programming language r (www.r-project.
org) and specifically packages DGC-genetics (LD, 
hardy-weinberg, genotype and allelic association) 
and haplo.stats (inferred haplotype association), 
linear models were used to examine differences 
in traits that were measured once only, with added 
random effects (linear mixed-effects models) for 
the traits where measurements were replicated 
(midupperarm, waist circumference, blood pressure 
and others). All models were adjusted for age and 
gender, while those for midupperarm were also 
adjusted for site of measurement. effect estimates 
are derived from the same models. because only one 
t/t homozygote was observed for rs997509, it was 
decided to combine it with the c/t heterozygote and 
analyse it as a dichotomous genotype for estimating 
the effect of the t allele. no rare-allele-homozygotes, 
G/G, were observed for rs9402349. 
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 Genotype-association (2 degrees of freedom) 
was tested by coding genotype as a categorical 
factor and additive allelic association (1 degree of 
freedom) with a numerical variable, counting the 
number of smaller-frequency alleles. for rs9402349, 
because it is dichotomous, the analysis is the 
same for genotype as for allelic association. we 
inferred haplotypes from the genotypes of 
the three variants and compared frequencies 
of obese and control subjects.
results  
the clinical characteristics of 64 obese cases and 
64 controls are summarised in Table 1. Significant 
differences between obese and control subjects 
were noted for fasting blood glucose, diastolic 
blood pressure and hdl cholesterol levels after 
adjusting for gender. hdl cholesterol also differed 
significantly between the genders, after adjusting 
for body size. females had higher hdl-cholesterol 
levels, waist/hip ratios, and sum of skinfolds after 
adjusting for gender and repeated measures. the 
genotype distributions of all variants studied were 
in hardy-weinberg equilibrium in both obese and 
control subjects. k121Q and rs997509 showed tight 
linkage disequilibrium in the cases (d’ = 0.999, P < 
0.01), whereas k121Q and rs9402349 showed tight 
linkage disequilibrium in the controls (d’ =1.0, P = 
0.02). the observed differences in allelic distribution 
of K121Q and rs9402349 did not differ significantly, 
whilst that of rs997509 did differ significantly between 
obese and controls (p=0.0100). the effect of the of 
rs997509 t allele was studied after adjustments 
for age and gender and was found to significantly 
increase the risk of being obese, p = 0.0238. the 
significance of this association was independent 
of the effects of the other two snPs (table 2). 
table 1 
Characteristics of cohort, stratified by age and status. Values are mean ± standard deviation. P-values are from the 
same model - adjusted for each other, (P-value for equality of status groups is adjusted for gender and vice versa
   obese   norml weight                                                   
 female  male  female  male      p-value 
No 48  16 48  16  status  Gender 
Age (years)  13.2±2.7  13.2±2.6  12.9±2.7  13.2±2.7  0.6442  0.8192 
weight (kg)  75.5±15.7  78±20.9  40.7±10.6  39.8±10.7 <0.0001  0.7989 
height (cm)  154.7±10.4  157.3±14  147.1±11.5  150.5±14.3  <0.0001  0.2134 
bmi (kg/m2)  31.2 ±4  30.9±4.3  18.4±2.8  17.2±1.8  <0.0001  0.2788 
midupperarm (cm)* 29.9±3.7  31.3±3.7  21.3±2.6  20.2±2.6  <0.0001  0.7172 
wc (cm)*  88.1±10.2  91.9±10.3  62.5±7.4  60.4±5.7  < 0.0001  0.6354 
hP (cm)*  107.4±11.5  107.9±14.3  81.8±10.3  75.7±7  < 0.0001  0.2798 
whr (ratio)*  0.823±0.061 0.855±0.051  0.77±0.047  0.791±0.025  < 0.0001  0.0057 
skinfold (cm)**  2.27±0.99 2.29±0.91  0.89±0.33  0.53±0.14  < 0.0001  0.0478 
sbP (mm hg) *  111.8±12.2  117.6±15.6  109.4±66.9  102.4±14.2  0.2050  0.9076 
dbP (mm hg)*  69.3±10.3  70.7±12.4  66.1±11.3  59.3±12.2  0.0017  0.1484 
FBG (mmol/L)  4.25±0.66  4.74±0.76  4±0.71  4.03±0.89 0.0049 0.0871
tc (mmol/l)  3.7±0.71  3.42±0.67  3.77±1.16  3.39±0.85 0.7831 0.0776
TG (mmol/L)  0.796±0.305  0.919±0.428  0.795±0.532  0.767±0.248 0.5979 0.5739
hdl-c (mmol/l) 0.931±0.334  0.718±0.204  1.137±0.382  0.976±0.316  0.0004  0.0074 
ldl-c (mmol/l)  2.42±0.58  2.58±0.7  2.48±1.52  2.15±0.7  0.7430  0.7443 
* replicated measurements; ** measured at 3 different sites; wc waist circumference; hP, hip circumference; 
WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; 
TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density 
lipoprotein cholesterol. 
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table 2
Allelic and genotype counts (n), frequencies (f) and p-values for corresponding tests of association with obesity 
status. Adjusted p-values are all from the same model; each is adjusted for the effect of the other two variants. 
       obese       normal    Adjusted 
 no f  no f P-value p-value 
 rs997509  (n = 24)    (n = 33) 
 c  37  0.77  62  0.94 
 t  11  0.23  4  0.06  0.0100 
 c/c  14  0.58  29  0.88 
 c/t  9  0.38  4  0.12
 t/t*  1  0.04  0  0  0.0337 0.0238
 rs1044498  (n = 61)     (n = 57)
 c  64  0.52  68  0.6
 A  58  0.48  46  0.4  0.2445
 c/c  20  0.33  20  0.35
 A/c  24  0.39  28  0.49 
 A/A  17  0.28  9  0.16  0.3033  0.1790 
 rs9402349  (n = 59)    (n = 42) 
 t  109  0.92  76  0,9 
 G  9  0.08  8  0.1  0.7276 
 t/t  50  0.85  34  0.81 
 T/G  9  0.15  8  0.19  0.7276  0.7041 
* one t/t homozygote observed for rs997509, was combined with the t/c heterozygote and 
analysed as a dichotomous genotype for estimating the effect of the t allele. 
The SNP rs997509 was significantly associated with 
weight, bmi, skinfold thickness, midupperarm, waist 
and hip circumferences (table 3a). the estimated 
effect of the t allele was an increase of 0.64 cm 
in skinfold thickness, 3.0 cm in midupperarm 
circumference, 8.6 cm in waist circumference, 8.9 
cm in hip circumference, 10.2 kg in weight and a 
corresponding 4.9 kg/m2 in bmi respectively, (table 
3b). the most frequent rs997509-k121Q-rs9402349 
haplotype was cAt, observed in more than 40% 
of normal and obese subjects. haplotype tct was 
significantly more frequent in obese (25%) than control 
subjects (5%) with odds ratio = 4.24 (95% ci: 1.24 to 
14.53) compared to CAT, whilst CCT was significantly 
more prevalent in controls (45%) than obese subjects 
(24%) with odds ratio of obesity 0.42 (95% ci: 0.19 
to 0.98) compared to cAt (table 4). As haplotypes 
containing rs9402349 G were very rare (f < 0.05), we 
present an analysis of the rs997509-k121Q haplotype 
in table 5. individuals carrying both the 121Q and 
the t allele of rs997509 were more associated with 
obesity (odds ratio = 3.085, 95% ci: 1.13 to 13.09) 
whilst those carrying the c allele of rs997509 in the 
presence of 121Q were likely to be lean with odds 
ratio of obesity 0.41 (95% ci: 0.19 to 0.87).
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table 3a
P-values for genotype association tests with clinical and metabolic syndrome characteristics, adjusted for 
age, gender and replicated measurements (marked *). Skinfold was also adjusted for the fact that the folds 
were measured at different sites. Sizes of significant effects and their standard errors are in Table 3 b.  
   Genetic association
characteristic  rs997509 k121Q rs9402349
weight (kg) 0.0366  0.5267  0.6905
height (cm)  0.9896  0.8479  0.8199
bmi (kg/m2)  0.0090  0.5810  0.6666
midupperarm (cm)  0.0220  0.5356  0.9225
wc (cm)  0.0347  0.3683  0.9542
hP (cm) 0.0379  0.2690  0.5212
whr ratio 0.3861  0.8439  0.1076
skinfold (cm)  0.0068  0.5095  0.9149
sbP (mm hg)  0.7793  0.4153  0.9588 
dbP (mm hg)  0.3542  0.6308  0.9556 
FBG (mmol/L)  0.2660  0.7462  0.3339 
tc (mmol/l)  0.2775  0.3379  0.4367 
TG (mmol/L) 0.9231  0.9890  0.4977 
hdl-c (mmol/l)  0.8805  0.0581  0.4309 
ldl-c (mmol/l)  0.7361  0.4638  0.5414 
table 3b
Estimated sizes of effect of T. allele of rs997509 and their standard errors for significant associations  
trait  effect standard error 
weight (kg)  10.2  4.9
bmi (kg/m2) 4.6  1.7
midupperarm (cm) 3.0  1.3
wc (cm)  8.6  4.0
  HP (cm)  8.9 4.2    
skinfold (cm)  0.64  0.23
table 4
Inferred haplotype frequencies in obese and control subjects, in decreasing order of pooled frequency.
  
               haplotype             frequency 
rs997509  rs1044498  rs9402349  control  obese 
c  A t 0.40   0.44 
c  c  t  0.45   0.24 
t  c  t  0.05   0.25 
C  C  G  0.08   0.05 
C  A  G  <0.01  0.03 
T  C G  0.01  <0.01
T  A  G  <0.01  <0.01
t  A t  - <0.01  
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discussion
in this study we provide evidence that the t allele 
or enPP1 rs997509 is strongly associated with 
obesity in mixed ancestry children from the western 
cape, south Africa. moreover, we show that the 
estimated effect of the T. allele was an increase of 
10.2 kg in weight and a corresponding 4.9 kg/m2 
in bmi. Previously, the rs997509 T. allele has been 
associated with diabetes and metabolic abnormalities 
in obese children (16,17). in contrast, bochenski 
et al., did not find an association between the 
rs997509 T. allele and obesity in Polish caucasians.
the haplotype carrying the minor T. allele of 
rs997509 and 121 Q was particularly associated 
with type  2 diabetes  among obese subjects 
possibly due to the presence of rs997509 
T.  al le le  (16) .  recently,  santora  et  aI . , 
reported a strong association between rs997509 
variant and insulin resistance, metabolic syndrome 
and IGT in obese children and adolescents from 
Naples, Italy (17). The glucose levels were significantly 
higher in obese learners, we did not find any association 
between the rs997509 T. allele and glucose levels, our 
findings suggest that the T. allele of rs997509 variant 
may predispose individuals to different metabolic 
syndrome traits according to population groups. the 
enPP1 k121Q polymorphism that had been strongly 
associated with metabolic traits had also shown 
different outcomes regarding its effect on insulin 
resistance, type 2 diabetes and obesity in different 
populations, for example, this variant was associated 
with type 2 diabetes in caucasians living in the united 
states (22, 23) and finland (24), but not in swedish 
caucasians (25).
 Another observation in this study was that the 
rs997509 t allele also showed strong associations with 
other indices of obesity. the waist circumference is 
commonly used as an indicator of central obesity, and 
its metabolic consequences, insulin resistance and 
type 2 diabetes (26). recognition of distinct gender 
and ethnic differences in body fat distribution has 
led to the use of different waist circumference cut-off 
points in the classification of central obesity (26, 27). 
the mixed ancestry population of south Africa is a 
combination of european settlers and the indigenous 
Africans. though these associations may be unique 
to this population group, they buttress the effect 
of rs997509 on obesity and indirectly on metabolic 
syndrome traits. 
 similar to observations reported in African-
Americans, the enPP1 121Q allele frequency was 
high in our cohort (28,29). the 121Q allele frequency 
has been shown to differ greatly between ethnic 
groups with the least number of carriers amongst 
caucasians and higher numbers in Asian indians 
and African-Americans (22, 23, 28, 29). though the 
African-Americans have been shown to have the 
highest 121Q allele frequency, no associations with 
bmi or obesity were demonstrated in previous studies 
(28, 29). Likewise, in this study we did not find any 
association between k121Q and obesity. individuals 
carrying the 121Q and the t allele of rs997509 were 
more associated with obesity whilst those carrying 
the c allele of rs997509 in the presence of 121Q were 
likely to be lean. These findings seem to indicate 
that 121Q does not contribute to obesity and that 
the effect of the t allele of rs997509 is independent. 
on the other hand both co-existence of the t allele 
of rs997509 and k121 were rare in our study group, 
with inferred frequencies below 1%. it is likely that the 
tA haplotype does not exist in this population at all. 
 the major limitation of this study is the small 
sample size, also the snPs could not be genotyped 
in all individuals due to the limited amount of dnA 
obtained from the ftA card as venous blood was only 
collected in learners aged  ≥16 years. This could result 
in us not having enough power to detect significant 
differences. furthermore, this small sample could not 
allow for any sub-grouping such as gender-specific 
analysis, gender and ethnic differences in the enPP1 
region have been reported( 22,23,28,29,30). therefore, 
these preliminary findings should be interpreted with 
caution, however they warrant further investigation 
on a larger samples size. in conclusion, our results 
concur with previous reports that enPP1 variants 
contribute to obesity. Our findings suggest that 
enPP1 polymorphisms may contribute to different 
metabolic characteristics, all of which are associated 
with insulin resistance in mixed ancestry children of 
south Africa. 
table 5
Association of inferred rs997509 and K121Q haplotype with obesity. Odds ratios are relative to CA 
       haplotype       frequency   odds ratio
rs997509  k121Q control  obese  or       95% ci
c c 0.54  0.29  0.41  0.19  0.87
c A  0.40 0.47  1.00 
t  c 0.06 0.24 3.85 1.13  13.09
t  A  – – – – 
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